Personalized Dendritic Cell Vaccines —Recent Breakthroughs and Encouraging Clinical Results
Conclusions
The development and success of DC-based immunotherapies has been hampered by several factors; (1) the immunosuppressive tumor microenvironment, particularly in advanced stage of the disease (2) the limited capacity of systemically administered DC to localize to the tumor-draining lymph nodes, (3) the low avidity of TAAs-specific T cells, and (4) the lack of reliable prognosis biomarkers. The rapidly increasing knowledge about DC subsets and the tumor-induced suppressive microenvironment must be exploited to design novel and improved cancer vaccines. The future of DC vaccines will certainly rely on combination therapies. As discussed in this review, recent studies have shown the great potential of such strategies, especially when using personalized DC vaccines. Overcoming the cancer immunosuppressive environment will reveal the real therapeutic potential of such DC vaccine.
Author Contributions
BM-G and KB wrote the manuscript. All authors, BM-G, KB, CB, POG, and LEK contributed to manuscript revision, read and approved the submitted version.
Conflict of Interest Statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Acknowledgments
The research leading to these results has received funding from the European Commission's H2020 Programme and the Swiss Government under grant agreement number 635122, and a grant by the Ovacure ...
Source: Frontiers in Immunology - Category: Allergy & Immunology Source Type: research
More News: Acute Leukemia | Acute Myeloid Leukemia | Allergy & Immunology | Avastin | Biology | Bone Marrow Aspiration and Biopsy | Brain Tumor | Breast Cancer | Breast Carcinoma | Cancer | Cancer & Oncology | Cancer Therapy | Cancer Vaccines | Carcinoma | Chemotherapy | Clinical Trials | Colorectal Cancer | Dermatology | Environmental Health | Epithelial Cancer | Eye Cancers | Genetics | Glioma | Grants | Head and Neck Cancer | HIV-Leishmania Co-infection | Hormone Refractory Prostate Cancer | Hormones | Immunotherapy | India Health | Kidney Cancer | Leukemia | Lung Cancer | Lymphoma | Melanoma | Men | Molecular Biology | Non-Small Cell Lung Cancer | Ovarian Cancer | Ovaries | Pancreas | Pancreatic Cancer | PET Scan | Prostate Cancer | Renal Cell Carcinoma | Science | Skin | Skin Biopsy | Skin Cancer | Study | Switzerland Health | Temodar | Toxicology | Ultrasound | Uveal Melanoma | Vaccines